PFE. Pfizer Announces Top-Line Results Of Prevenar 13® Phase 3 Trial In Adults 18 To 49 Years Of Age Data Support EU Regulatory Filing and Planned Worldwide Regulatory Filings For This Age Group http://finance.yahoo.com/news/pfizer-announces-top-line-results-120000890.html stockcharts.com/c-sc/sc?s=PFE&p=D&yr=0&mn=4&dy=0&i=t69329776171&r=1349353092725